Pulpitis - Irreversible
Conditions
Keywords
Pulpitis, irreversible Pulpitis,, Diclofenac Potassium, Premedication, Preoperative Analgesic, Postoperative pain
Brief summary
The purpose of this study is to assess the effect of preoperative a single-dose of 50 mg diclofenac potassium on postoperative endodontic pain in mandibular molars with symptomatic irreversible pulpitis.
Detailed description
Patients with moderate-to-severe preoperative pain are selected. Patients receive either a single-dose of 50 mg diclofenac potassium (group A) or a placebo tablet as a control (group B). All patients receive the assigned premedication one hour before single-visit root canal treatment. Postoperative endodontic pain is measured at the following time points: 6 , 12,24,48 h after treatment. The incidence of analgesic intake is also recorded.
Interventions
A 50 mg tablet of the medication to be taken one hour before initiation of endodontic treatment.
A placebo will be taken one hour before initiation of endodontic treatment.
Sponsors
Study design
Intervention model description
The patients will be randomly divided into 2 groups: Experimental group: 50 mg Diclofenac Potassium to be administered one hour before treatment. Control group: Placebo to be administered one hour before treatment.
Eligibility
Inclusion criteria
* Patients with active pain (moderate-to-severe) in mandibular molars. * Patients with prolonged response to cold testing and electric pulp tester. * Patient with the ability to understand and use pain scales. * Patient with vital coronal pulp tissue on access. * Patient who accept to enroll to the study.
Exclusion criteria
* Patients' allergies or any other contraindication to diclofenac potassium or articaine. * Pregnant and lactating females. * Patients having pain medication in the last 6 hours. * Patient has more than one symptomatic mandibular tooth in the same quadrant. * Patients with periradicular pathosis and/or radiolucency other than widened periodontal ligaments. * Patients with active peptic ulcer and gastrointestinal disorders. * Patients with history of bleeding problems or anticoagulant use within the last month.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative endodontic pain | Up to 2 days after endodontic treatment | Pain after completion root canal treatment measured by Heft-parker visual analogue scale. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Analgesic intake | Up to 2 days after endodontic treatment | The incidence of analgesic intake is recorded |
Countries
Egypt